Listen to Professor Liebl outline when and how he uses these modern agents. Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.

Listen to Professor Liebl outline when and how he uses these modern agents. Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.

Listen to Professor Liebl outline when and how he uses these modern agents. Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.

Share ASCEND Talking Diabetes

Sign up to save your podcasts

ASCEND Talking Diabetes

ASCEND Talking Diabetes episodes

About ASCEND Talking Diabetes